(PharmaNewsWire.Com, December 07, 2019 ) According to research report qPCR reagents market is poised to reach $1,893.9 Million by 2020 From USD 1,307.0 Million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020.
The qPCR reagents that are used for pathogen detection, forensic applications, and disease diagnosis offer a promising future to market aspirants focusing on expanding their revenue base in the market. Their growth is propelled by the increasing R&D to develop and commercialize novel products, growing market adoption of gene-based diagnostic techniques, and rising emphasis on effective & early disease diagnosis across major markets. Several companies such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., and Takara Bio are investing in these high-growth markets to gain higher profits and to increase their shares in the global qPCR reagents market.
Thermo Fisher Scientific Inc. (U.S.) held the leadership position in the global qPCR reagents market, with a share of ~40%,. The company has a broad product portfolio for qPCR reagents, including master mixes, enzymes, nucleotides, primers, reagents, as well as consumables, among others. The company has a strong geographic presence in more than 50 countries across the globe, with key markets being the U.S., China, Germany, and the U.K. The company focuses mainly on the development of technologically advanced qPCR instruments and supporting reagents that can be used for multiple applications. In line with this strategy, Thermo Fisher Scientific has launched several qPCR reagents in the last three years, including SYBR Green master mixes and Taqman qPCR kits, among others.
North America (particularly the U.S.) is expected to hold the largest share of qPCR reagents market during the forecast period. Factors such as high penetration of qPCR technologies among key end users, increasing public & private funding to expand the application base of qPCR, ongoing product advancements in the field of qPCR reagents, and continuous reduction in the average cost of genome sequencing are driving the growth of the North American market.
On the basis of packaging type, the qPCR reagents market is classified into two major segments core kits and mastermixes. The qPCR core kits segment is expected to account for the largest share of the global market.
On the basis of end user, the market is classified into five segments hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, and forensic laboratories. The hospitals and diagnostic centers segment is expected to account for the largest market share of qPCR reagents market.
Product development & commercialization, agreements, collaborations, and partnerships are the key strategies adopted by major players to strengthen their positions in the global qPCR reagents market.
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
